PTPN22 and type 1 diabetes mellitus: The autoimmunity-associated PTPN22 variant promotes NLRP3 activity, caspase-1 activation, and secretion of IL-1β and IL18, which might—at least partially—explain the pro-inflammatory character of this PTPN22 variant in T1D, RA and SLE development.